Cargando…
Resectable Pediatric Nonrhabdomyosarcoma Soft Tissue Sarcoma: Which Patients Benefit from Adjuvant Radiation Therapy and How Much?
It remains unclear which children and adolescents with resected nonrhabdomyosarcoma soft tissue sarcoma (NRSTS) benefit from radiation therapy, as well as the optimal dose, volume, and timing of radiotherapy when used with primary surgical resection. This paper reviews the sparse literature from cli...
Autores principales: | Million, Lynn, Donaldson, Sarah S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scholarly Research Network
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3316976/ https://www.ncbi.nlm.nih.gov/pubmed/22523704 http://dx.doi.org/10.5402/2012/341408 |
Ejemplares similares
-
Risk-stratified patients with resectable soft tissue sarcoma benefit from epirubicin-based adjuvant chemotherapy
por: Schenone, Aaron D, et al.
Publicado: (2014) -
Pediatric Soft Tissue and Bone Sarcomas in Tanzania: Epidemiology and Clinical Features
por: Siwillis, E. Mithe, et al.
Publicado: (2019) -
Which kind and how much physical activity?
por: Giordano, Ugo
Publicado: (2014) -
Which Soft Tissue Sarcoma Patients with Lung Metastases Should
not Undergo Pulmonary Resection?
por: van Geel, Albertus N., et al.
Publicado: (2002) -
Surgical resection with adjuvant brachytherapy in soft tissue sarcoma of the extremity – a case report
por: Guzik, Grzegorz, et al.
Publicado: (2012)